Sponsored
Color and style transformation, on the go — Lubrizol Life Science Beauty
Innospec: Leader in 1,4-dioxane free surfactants — Innospec Performance Chemicals
Wellness and Nutricosmetics: Free Ebook — Sabinsa
Providing Solubilizers in Personal Care Products that Consumers Want — Sensient Cosmetic Technologies
High Demand for Naturals Continues – Guide Formulary Accelerates Formulation Work — Natural Plant Products Inc.
Most Popular in Regulatory
- 1Unilever’s TRESemmé Shampoo Alleged to Cause Irritation, Hair Loss
- 2U.S. Federal Trade Commission Lays Down the Law on Deceptive CBD Claims
- 3FDA Adds 357 Voluntary Cosmetic Registrations in One Month
- 4FDA's Sanitizer Hotlist Cites Nevada Distributor, Calls Out Subpotency and Methanol
- 5EDQM Finds Allergenic Fragrances in ‘Perfume-Free’ Cosmetics
- 6FDA Issues Warning Letter for Eyebrow/Eyelash Growth Product Claims
- 7Endocrine Effects, Environmental Risk Feedback Sought for Dibutyl Phthalate, Bisphenols
- 8Regulating Risk: Fragrance Safety for the 21st Century
- 9Korean Cosmetic Regulations
- 10CIR Conclusion (continued): Parabens are Safe
Recent in Regulatory (page 8 of 40)
[update] EU Classifies TiO2 as 'Suspected' Carcinogen by Inhalation
Dec 11, 2019
Update: It's official. European legislators are moving forward with the proposal to classify TiO2 as a suspected Category 2 carcinogen by inhalation. The could spell trouble for sunscreen developers.
[Update] Purisys Touts Descheduling Under Farm Bill
Dec 9, 2019
Tim Jones, vice president of global API and OTC for Purisys, claimed, “Descheduling means our customers no longer need DEA registrations to work with Purisys materials.”
Gregg Renfrew of Beautycounter to Testify in Cosmetic Reform Hearing
Dec 4, 2019
“It's been over 80 years since Congress has passed comprehensive legislation that would protect consumers from harmful ingredients in personal-care and beauty products," said Beautycounter founder and CEO Gregg Renfrew.
U.S. FDA Issues 15 Warning Letters Over CBD Products
Nov 26, 2019
“We remain concerned that some people wrongly think that the myriad of CBD products on the market, many of which are illegal, have been evaluated by the FDA and determined to be safe," said FDA principal deputy commissioner Amy Abernethy, M.D., Ph.D.
Back to Basics IV: Product Labeling, Manufacturing and Launch
Nov 13, 2019 | Pascal Yvon, BioScience Expansion, LLC
The development of a new cosmetic product is an extensive, multistep process, from idea generation to market launch. This fourth article in a series explores the rules for later steps in the process: claims, labeling and manufacturing. Click through to the digital magazine for more.
Proposed 'Natural Cosmetics Act' Gains Traction with Indies
Nov 6, 2019
Could it finally be time that U.S. legislators ante up with a definition for "natural" cosmetics? The bill has been proposed, and indie brands are backing it—naturally.
FTC Hits Sunday Riley with Violations for Faked Sephora Reviews
Oct 29, 2019
“Dishonesty in the online marketplace harms shoppers, as well as firms that play fair and square,” said Andrew Smith, director of the FTC’s Bureau of Consumer Protection.
FDA Alert: New J&J Baby Powder Recall
Oct 18, 2019
According to the FDA, a test sample from one lot was found to contain chrysotile fibers, a type of asbestos. As such, Oct. 18, 2019, Johnson & Johnson voluntarily recalled the product.
A Closer Look at Cosmetic Claims
Sep 23, 2019
Claims cannot be considered legal unless they are truthful, and truthfulness requires evidence, which needs to be honest. Theresa Callaghan, Ph.D., explores these laws and the relationship between claims and consumers in a new book.
DSM Seeks FDA Sunscreen Monograph Approval of Bemotrizinol
Aug 29, 2019
DSM believes it is important for consumers in the USA to benefit from the efficacy and aesthetics that modern filters such as BEMT can provide. As such, the company is pushing for Monograph status.
Could the FDA Sunscreen Monograph See a New Addition?
Aug 28, 2019
It's been decades since the FDA's OTC Sunscreen Monograph welcomed a new addition; back then, it was avobenzone. Now, another could be joining the ranks.
EPA Eyes 20 Chemicals for High Priority Risk Evaluation, ACC Responds
Aug 23, 2019
"EPA is providing a 90-day comment period during which interested persons may provide comments on the proposed designations of High-Priority Substances for risk evaluation." Read on to learn more.
FOLLOW US: